The Artificial Intelligence Digital Therapeutics Platform becomes a companion to the current manual clinical process.
An industry renowned team has replicated and supplemented existing manual “Gold Standard” office based processes with mobile and home based administered solutions.
In the care of Multiple Sclerosis patients, the BeCareLink Artificial Intelligence (AI) Digital Therapeutics platform transforms the traditional Expanded Disability Status Scale (EDSS) and Multiple Sclerosis Functional Composite (MSFC) scoring system into a high precision measurement of disease status and treatment outcomes.
Patients use the mobile App while participating in their daily activities. This real time data provides a more accurate picture of how patients are impacted by their disease, its symptoms, how the disease progresses and the impact of their treatment in real life situations.
The patent-protected application comprises the following activities: